Marcus Schembri-Wischik, head of legal – data protection & clinical operations at TauRx Pharmaceuticals, explains why safeguarding data is as important as safeguarding health.

72.9% of early AI adopters in clinical trials reported shorter timelines in May. The same report found weak data foundations still blocking 75% from scaling. One number signals progress. The other signals where the accountability gap actually lives. Read the full article now. If this is the problem your team is working through — www.arclio.ai #ClinicalTrials #RegulatoryAffairs #FDA #ClinicalOperations #EnterpriseAI #LifeSciences #Pharma #AIGovernance #DrugDevelopment #ClinicalResearch #Arclio #MayRecap #NYTech #NewYorkAI

Discover the Essentials of ICH E6 (R2) – The Global Standard for Good Clinical Practice (GCP) Whether you're an investigator, Medical Affairs leader, clinical operations professional, or part of a research team—understanding ICH E6 (R2) is no longer optional. It’s the backbone of ethical, high-quality clinical trials. 🎯 In this tutorial, you’ll learn: What is ICH and why it was created The scope and purpose of the ICH E6 (R2) guideline A breakdown of the 13 core principles of GCP The structure of the E6 guideline and how to use it in your daily work Why understanding E6 matters for inspections, compliance, and patient safety 💡 Learn how this international guideline ensures trial credibility, protects participant rights, and aligns all stakeholders—from sponsors and investigators to ethics committees and monitors. 📌 Whether you're reviewing protocols, overseeing data, or engaging with trial sites—this tutorial will give you the foundation to lead with...

learn about Genelife Clinical Research Smarter Patient Recruitment Through Disease Surveillance

As cell and gene therapies (CGTs) progress from the laboratory to patient care, clinical centers face unique challenges in adapting to these groundbreaking treatments. Explore insights from Title21’s ...